Boehringer Ingelheim’s Post

View organization page for Boehringer Ingelheim, graphic

1,808,631 followers

As #pridemonth comes to an end, it's important to remember that #diversity remains a significant topic in many areas, including #clinicaltrials, where too many people are invisible. We need to ensure everyone is represented and has the same opportunity to benefit from medical progress. Read more about diversity in clinical trials here: https://lnkd.in/erYSU5db

View organization page for United Nations, graphic

5,554,767 followers

Human rights are for everyone, everywhere — no matter who you are or whom you love. 🖤🤎❤️🧡💛💚💙💜 Each of us can call out discrimination wherever we may see it. This Pride Month is an opportunity to stand up for equal rights and fair treatment of LGBTIQ people everywhere: http://unfe.org

  • No alternative text description for this image
USA and international Research .

Chief Executive Officer at USA and International Research Inc.

1w

Absolutely! Diversity in clinical trials is crucial for ensuring healthcare advancements benefit everyone equally. Let's continue striving for inclusivity beyond Pride Month. 

Like
Reply

To view or add a comment, sign in

Explore topics